These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36428474)

  • 41. Astroglia acquires a toxic neuroinflammatory role in response to the cerebrospinal fluid from amyotrophic lateral sclerosis patients.
    Mishra PS; Dhull DK; Nalini A; Vijayalakshmi K; Sathyaprabha TN; Alladi PA; Raju TR
    J Neuroinflammation; 2016 Aug; 13(1):212. PubMed ID: 27578023
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
    Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T
    PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In Amyotrophic Lateral Sclerosis Blood Cytokines Are Altered, but Do Not Correlate with Changes in Brain Topology.
    Polverino A; Rucco R; Stillitano I; Bonavita S; Grimaldi M; Minino R; Pesoli M; Trojsi F; D'Ursi AM; Sorrentino G; Sorrentino P
    Brain Connect; 2020 Oct; 10(8):411-421. PubMed ID: 32731760
    [No Abstract]   [Full Text] [Related]  

  • 44. MN-166 (ibudilast) in amyotrophic lateral sclerosis in a Phase IIb/III study: COMBAT-ALS study design.
    Oskarsson B; Maragakis N; Bedlack RS; Goyal N; Meyer JA; Genge A; Bodkin C; Maiser S; Staff N; Zinman L; Olney N; Turnbull J; Brooks BR; Klonowski E; Makhay M; Yasui S; Matsuda K
    Neurodegener Dis Manag; 2021 Dec; 11(6):431-443. PubMed ID: 34816762
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients.
    Saucier D; Wajnberg G; Roy J; Beauregard AP; Chacko S; Crapoulet N; Fournier S; Ghosh A; Lewis SM; Marrero A; O'Connell C; Ouellette RJ; Morin PJ
    Brain Res; 2019 Apr; 1708():100-108. PubMed ID: 30552897
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spinal but not cortical microglia acquire an atypical phenotype with high VEGF, galectin-3 and osteopontin, and blunted inflammatory responses in ALS rats.
    Nikodemova M; Small AL; Smith SM; Mitchell GS; Watters JJ
    Neurobiol Dis; 2014 Sep; 69():43-53. PubMed ID: 24269728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elucidation of Relevant Neuroinflammation Mechanisms Using Gene Expression Profiling in Patients with Amyotrophic Lateral Sclerosis.
    Won YH; Lee MY; Choi YC; Ha Y; Kim H; Kim DY; Kim MS; Yu JH; Seo JH; Kim M; Cho SR; Kang SW
    PLoS One; 2016; 11(11):e0165290. PubMed ID: 27812125
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CSF chitinase proteins in amyotrophic lateral sclerosis.
    Thompson AG; Gray E; Bampton A; Raciborska D; Talbot K; Turner MR
    J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1215-1220. PubMed ID: 31123140
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X
    Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: a multicenter study.
    Steinacker P; Feneberg E; Halbgebauer S; Witzel S; Verde F; Oeckl P; Van Damme P; Gaur N; Gray E; Grosskreutz J; Jardel CG; Kachanov M; Kuhle J; Lamari F; Maceski A; Del Mar Amador M; Mayer B; Morelli C; Petri S; Poesen K; Raaphorst J; Salachas F; Silani V; Turner MR; Verbeek MM; Volk AE; Weishaupt JH; Weydt P; Ludolph AC; Otto M
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 May; 22(3-4):276-286. PubMed ID: 33576252
    [No Abstract]   [Full Text] [Related]  

  • 51. Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics.
    Ryberg H; An J; Darko S; Lustgarten JL; Jaffa M; Gopalakrishnan V; Lacomis D; Cudkowicz M; Bowser R
    Muscle Nerve; 2010 Jul; 42(1):104-11. PubMed ID: 20583124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNAs as Biomarkers in Amyotrophic Lateral Sclerosis.
    Ricci C; Marzocchi C; Battistini S
    Cells; 2018 Nov; 7(11):. PubMed ID: 30463376
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adiponectin levels in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients: possible influence on neuroinflammation?
    Bossolasco P; Cancello R; Doretti A; Morelli C; Silani V; Cova L
    J Neuroinflammation; 2017 Apr; 14(1):85. PubMed ID: 28427413
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial.
    Camu W; Mickunas M; Veyrune JL; Payan C; Garlanda C; Locati M; Juntas-Morales R; Pageot N; Malaspina A; Andreasson U; Kirby J; Suehs C; Saker S; Masseguin C; De Vos J; Zetterberg H; Shaw PJ; Al-Chalabi A; Leigh PN; Tree T; Bensimon G
    EBioMedicine; 2020 Sep; 59():102844. PubMed ID: 32651161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A phase II open label clinical study of the safety, tolerability and efficacy of ILB® for Amyotrophic Lateral Sclerosis.
    Logan A; Nagy Z; Barnes NM; Belli A; Di Pietro V; Tavazzi B; Lazzarino G; Lazzarino G; Bruce L; Persson LI
    PLoS One; 2022; 17(5):e0267183. PubMed ID: 35613082
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of heat shock proteins in Amyotrophic Lateral Sclerosis: The therapeutic potential of Arimoclomol.
    Kalmar B; Lu CH; Greensmith L
    Pharmacol Ther; 2014 Jan; 141(1):40-54. PubMed ID: 23978556
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis.
    Mandrioli J; Amedei A; Cammarota G; Niccolai E; Zucchi E; D'Amico R; Ricci F; Quaranta G; Spanu T; Masucci L
    Front Neurol; 2019; 10():1021. PubMed ID: 31620079
    [No Abstract]   [Full Text] [Related]  

  • 58. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis.
    Tanaka K; Kanno T; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Ikeda JE
    Exp Neurol; 2011 Nov; 232(1):41-52. PubMed ID: 21867702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
    Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1
    Bonifacino T; Provenzano F; Gallia E; Ravera S; Torazza C; Bossi S; Ferrando S; Puliti A; Van Den Bosch L; Bonanno G; Milanese M
    Neurobiol Dis; 2019 Sep; 129():79-92. PubMed ID: 31102766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.